InsideArbitrage Event Driven Monitor – January 14, 2025
Merger Arbitrage
- ITCI: The acquisition of Intra-Cellular Therapies, Inc. (ITCI) by Johnson & Johnson (JNJ), for a closing value of $14.6 billion. Under the terms of the agreement, Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies for a payment of $132.00 per share in cash. (Press Release)
- ENFN: The acquisition of Enfusion, Inc. (ENFN) by Clearwater Analytics Holdings, Inc. (CWAN) for $1.5 billion in a cash-plus stock transaction. As per the terms of the agreement, Enfusion shareholders will receive a total consideration of $11.25 per share, comprised of $5.85 in cash and $5.40 per share in Clearwater Common Stock. (Press Release)
- VCSA: Alan Liu and Luis Sosa each submitted a letter to the Board of Directors of Vacasa (VCSA) on January 10, 2025, submitting their respective resignations as company directors, effective immediately.
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.
